Stocks Overview

LAST PRICE
165.4400
TODAY'S CHANGE (%)
Trending Up3.3000 (2.0353%)

Bid / Lots
165.0000/ 3
Ask / Lots
165.4000/ 1
Open / Previous Close
162.9000 / 162.1400
Day Range
Low 162.1600
High 165.9800
52 Week Range
Low 130.9601
High 182.8900
Volume
5,095,099
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 162.14
Time	Volume	ABBV
09:32 ET	78501	163.23
09:34 ET	51469	164.73
09:36 ET	87652	165.36
09:38 ET	38606	164.62
09:39 ET	17361	164.52
09:41 ET	92932	164.95
09:43 ET	34101	165.51
09:45 ET	21646	164.61
09:48 ET	25788	163.985
09:50 ET	19540	164.09
09:52 ET	16907	163.57
09:54 ET	13461	163.6375
09:56 ET	12279	163.6415
09:57 ET	6021	163.25
09:59 ET	6691	163.33
10:01 ET	9930	163.36
10:03 ET	8644	163.49
10:06 ET	10397	163.39
10:08 ET	6170	163.23
10:10 ET	12703	163.4
10:12 ET	8326	163.47
10:14 ET	6315	163.71
10:15 ET	10176	163.62
10:17 ET	7309	163.575
10:19 ET	6869	163.5799
10:21 ET	9226	163.57
10:24 ET	19309	163.91
10:26 ET	13635	163.5291
10:28 ET	12353	163.6568
10:30 ET	7586	163.5869
10:32 ET	26916	163.375
10:33 ET	10588	163.6
10:35 ET	9536	163.615
10:37 ET	5810	163.48
10:39 ET	6598	163.475
10:42 ET	7424	163.55
10:44 ET	9352	163.77
10:46 ET	7808	163.87
10:48 ET	3973	163.95
10:50 ET	14202	164.11
10:51 ET	14093	164.54
10:53 ET	4787	164.465
10:55 ET	16958	164.6
10:57 ET	16035	164.66
11:00 ET	7275	164.645
11:02 ET	4142	164.84
11:04 ET	8670	164.775
11:06 ET	6183	164.765
11:08 ET	4250	164.49
11:09 ET	12498	164.24
11:11 ET	8785	164.46
11:13 ET	7897	164.3094
11:15 ET	5852	164.32
11:18 ET	11885	164.395
11:20 ET	10392	164.46
11:22 ET	5029	164.3
11:24 ET	6242	164.24
11:26 ET	3839	164.36
11:27 ET	14429	164.67
11:29 ET	22804	164.765
11:31 ET	12222	164.65
11:33 ET	5463	164.72
11:36 ET	6521	164.77
11:38 ET	6756	164.66
11:40 ET	6437	164.795
11:42 ET	8671	164.7318
11:44 ET	7885	164.735
11:45 ET	4819	164.6599
11:47 ET	4330	164.75
11:49 ET	8783	164.71
11:51 ET	3960	164.78
11:54 ET	6426	164.65
11:56 ET	7240	164.57
11:58 ET	5206	164.65
12:00 ET	4128	164.675
12:02 ET	2000	164.74
12:03 ET	3781	164.555
12:05 ET	7753	164.52
12:07 ET	6509	164.6
12:09 ET	11692	164.61
12:12 ET	4790	164.75
12:14 ET	3561	164.805
12:16 ET	5969	164.74
12:18 ET	4614	164.68
12:20 ET	2957	164.58
12:21 ET	6438	164.76
12:23 ET	4001	164.8
12:25 ET	11817	164.88
12:27 ET	6588	164.93
12:30 ET	4937	164.93
12:32 ET	7863	164.945
12:34 ET	13055	165.09
12:36 ET	5158	165.15
12:38 ET	4572	165.15
12:39 ET	5678	165.165
12:41 ET	5018	165.17
12:43 ET	8637	165.205
12:45 ET	3720	165.175
12:48 ET	7227	165.215
12:50 ET	9190	165.225
12:52 ET	2712	165.21
12:54 ET	9152	165.1
12:56 ET	9776	165
12:57 ET	9906	165.01
12:59 ET	6673	165.09
01:01 ET	4518	165.1
01:03 ET	5030	165.22
01:06 ET	8558	165.28
01:08 ET	50118	165.02
01:10 ET	8342	165.15
01:12 ET	10799	165.27
01:14 ET	7651	165.2168
01:15 ET	10196	165.2
01:17 ET	13987	165.258
01:19 ET	11624	165.37
01:21 ET	10435	165.22
01:24 ET	6669	165.36
01:26 ET	10397	165.1319
01:28 ET	5384	165.19
01:30 ET	24627	165.26
01:32 ET	9082	165.27
01:33 ET	4146	165.32
01:35 ET	4015	165.14
01:37 ET	6271	165.0499
01:39 ET	3757	165.06
01:42 ET	5640	165.12
01:44 ET	5652	165.095
01:46 ET	6577	165.11
01:48 ET	14506	165.34
01:50 ET	5129	165.35
01:51 ET	6488	165.39
01:53 ET	5017	165.41
01:55 ET	10770	165.4
01:57 ET	5517	165.33
02:00 ET	8265	165.3
02:02 ET	14498	165.42
02:04 ET	12368	165.465
02:06 ET	28030	165.6
02:08 ET	7875	165.73
02:09 ET	7822	165.79
02:11 ET	8100	165.69
02:13 ET	12808	165.7
02:15 ET	7043	165.66
02:18 ET	4932	165.63
02:20 ET	13077	165.56
02:22 ET	3785	165.64
02:24 ET	7773	165.735
02:26 ET	33150	165.69
02:27 ET	1920	165.72
02:29 ET	16050	165.79
02:31 ET	8990	165.74
02:33 ET	11776	165.85
02:36 ET	6680	165.74
02:38 ET	11296	165.82
02:40 ET	6822	165.765
02:42 ET	7028	165.81
02:44 ET	14094	165.9
02:45 ET	7745	165.94
02:47 ET	18601	165.8389
02:49 ET	15356	165.74
02:51 ET	10928	165.884
02:54 ET	6570	165.97
02:56 ET	5516	165.92
02:58 ET	9480	165.85
03:00 ET	6970	165.82
03:02 ET	7709	165.8
03:03 ET	9002	165.585
03:05 ET	17387	165.6625
03:07 ET	5994	165.52
03:09 ET	9753	165.42
03:12 ET	8138	165.38
03:14 ET	9013	165.44
03:16 ET	14899	165.525
03:18 ET	19447	165.34
03:20 ET	12983	165.26
03:21 ET	16062	165.26
03:23 ET	6477	165.26
03:25 ET	7010	165.25
03:27 ET	6283	165.215
03:30 ET	6704	165.175
03:32 ET	17471	165.27
03:34 ET	17931	165.44
03:36 ET	10913	165.23
03:38 ET	12923	165.11
03:39 ET	16099	165.185
03:41 ET	11885	165.24
03:43 ET	16918	165.14
03:45 ET	14551	165.26
03:48 ET	27856	165.265
03:50 ET	28712	165.245
03:52 ET	84492	165.535
03:54 ET	46529	165.49
03:56 ET	70749	165.59
03:57 ET	86596	165.46
03:59 ET	1066872	165.44

Data delayed at least 15 minutes.

Today
- Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
- AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383, from 9 hours ago by Dow Jones
  9 hours ago by Dow Jones
- DJ AbbVie Raised to Buy From Hold by HSBC, from 12 hours ago by Dow Jones
  12 hours ago by Dow Jones
Yesterday
- Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses, from 11:06AM ET on Tuesday Jun 04, 2024 by Dow Jones
  11:06AM ET on Tuesday Jun 04, 2024 by Dow Jones
- RINVOQ(R) (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis, from 8:30AM ET on Tuesday Jun 04, 2024 by Dow Jones
  8:30AM ET on Tuesday Jun 04, 2024 by Dow Jones

1 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesABBV AbbVie Inc	284.7B	49.3x	-6.05%
United StatesMRK Merck & Co Inc	318.0B	145.1x	-43.23%
United StatesAZN AstraZeneca PLC	240.7B	39.6x	+17.52%
United StatesNVS Novartis AG	226.2B	23.9x	-5.59%
United StatesPFE Pfizer Inc	162.4B	-486.1x	-7.10%
United StatesRHHBY Roche Holding AG	209.5B	16.7x	+3.28%
As of 2024-06-05

AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology, which include Humira, Skyrizi and Rinvoq; oncology, which include Imbruvica, Venclexta/Venclyxto, Epkinly and Elahere; aesthetics products, which include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience, which include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy and Qulipta; eye care, which consists of Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis and Other eye care, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. It also offers investigational asset named NX-13, oral NLRX1 agonist (a member of the NOD-like receptor family), which is in Phase II for the treatment of ulcerative colitis (UC) and Crohn's disease (CD).

Contact Information

Headquarters: 1 N Waukegan RdNORTH CHICAGO, IL, United States 60064
Phone: 847-932-7900
Fax: 302-655-5049

Executives

Executive Chairman of the Board: Richard Gonzalez
Chief Executive Officer, Director: Robert Michael
Chief Financial Officer, Executive Vice President: Scott Reents
Chief Human Resource Officer, Executive Vice President: Timothy Richmond
Executive Vice President, General Counsel, Company Secretary: Perry Siatis

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$284.7B
Revenue (TTM)	$54.4B
Shares Outstanding	1.8B
Dividend Yield	3.75%
Annual Dividend Rate	6.2000 USD
Ex-Dividend Date	04-12-24
Pay Date	05-15-24
Beta	0.58
EPS	$3.36
Book Value	$5.87
P/E Ratio	49.3x
Price/Sales (TTM)	5.2
Price/Cash Flow (TTM)	19.4x
Operating Margin	23.50%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

AbbVie Inc
NYSE:ABBVUnited States

Search Criteria

Charts

Recent News

Today

Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses, from 7 hours ago by Dow Jones

AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for Investigational Asset ABBV-383, from 9 hours ago by Dow Jones

DJ AbbVie Raised to Buy From Hold by HSBC, from 12 hours ago by Dow Jones

Yesterday

Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses, from 11:06AM ET on Tuesday Jun 04, 2024 by Dow Jones

RINVOQ(R) (upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis, from 8:30AM ET on Tuesday Jun 04, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar